Title of article :
Inactivation of medium-chain acyl-CoA dehydrogenase by oct-4-en-2-ynoyl-CoA
Author/Authors :
Jia Zeng، نويسنده , , Guisheng Deng، نويسنده , , Wenhua Yu، نويسنده , , Ding Li، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2006
Abstract :
Mitochondrial medium-chain acyl-CoA dehydrogenase is a key enzyme for the β-oxidation of fatty acids, which catalyzes the FAD-dependent oxidation of a variety of acyl-CoA substrates to the corresponding trans-2-enoyl-CoA thioesters. Oct-4-en-2-ynoyl-CoA was identified as a new irreversible inhibitor of acyl-CoA dehydrogenase, and kinetic parameters KI and kinact were determined to be 11 μM and 0.025 min−1, respectively. Triple bond between C2 and C3 of the inhibitor was identified as the functional group responsible for enzyme inactivation, and Michael addition is proposed as the mechanism for this inactivation, which is a new pathway for inactivation of MCAD by inhibitors. The inhibitor may become a lead for further development for treating non-insulin-dependent diabetes mellitus.
Keywords :
Acyl-CoA dehydrogenase , Oct-4-en-2-ynoyl-CoA , Michael addition , Diabetes
Journal title :
Bioorganic & Medicinal Chemistry Letters
Journal title :
Bioorganic & Medicinal Chemistry Letters